Zacks Investment Research upgraded PharMerica Corporation (NYSE:PMC) to Hold in a report released today.
- Updated: September 22, 2016
Just yesterday PharMerica Corporation (NYSE:PMC) traded 5.62% higher at $28.17. PMC’s 50-day average is $25.03 and its two hundred day average is $24.60. With the last close up 14.53% relative to the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Volume of trade was up over the average, with 1,027,188 shares of PMC changing hands over the typical 288,059
Zacks Investment Research has upgraded PharMerica Corporation (NYSE:PMC) to Hold in a report released on 09/23/2016.
Recent Performance Chart
PharMerica Corporation has PE ratio of 29.10 with a one year low of $19.79 and a one year high of $35.81 and has a total market value of $0.
A total of 7 equity analysts have released a ratings update on PMC. One equity analyst rating the company a strong buy, three equity analysts rating the company a buy, two equity analysts rating the company a hold, one equity analyst rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $30.43.
About PharMerica Corporation (NYSE:PMC)
PharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Its institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. Its specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital. Its specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.